Search

Home > The Journal. > Philip Morris Tried to Pivot to Pharmaceuticals. It Didn't Go Well.
Podcast: The Journal.
Episode:

Philip Morris Tried to Pivot to Pharmaceuticals. It Didn't Go Well.
Category: News & Politics
Duration: 00:16:19
Publish Date: 2023-10-04 19:55:00
Description:

In 2021, Philip Morris International acquired three pharmaceutical companies for more than $2 billion as part of a plan to pivot away from cigarette sales. The deals inserted the Marlboro maker into the market for inhalers and other treatments for respiratory diseases that are linked to cigarette smoking. We talked with WSJ’s Jennifer Maloney about how the company’s plan hasn’t gone so smoothly.


Further Listening:

- The ‘Existential Threat’ Facing Big Tobacco 

- The Fight Over a Menthol Cigarette Ban 


Further Reading:

- Marlboro Maker Hits Reset on $2 Billion Bet on Medicine 

- Philip Morris Raises Offer for Swedish Match and Buys U.S. Rights for IQOS 


Learn more about your ad choices. Visit megaphone.fm/adchoices
Total Play: 0

Some more Podcasts by The Wall Street Journal

1K+ Episodes
WSJ Opinion: .. 600+     90+
200+ Episodes
WSJ Secrets .. 50+     1
300+ Episodes
WSJ The Futu .. 40+     10+
3K+ Episodes
WSJ Tech New .. 20+     20+
20+ Episodes
WSJ Minute B .. 70+     1
500+ Episodes
WSJ What's N .. 100+     10+
1K+ Episodes
WSJ Your Mon .. 10+     3
2K+ Episodes
WSJ What’s ..     6